Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36^th Annual Healthcare Conference being held in New York on December 3-5, 2024.

Read more at globenewswire.com